US Vendor Neutral Archive (VNA) & PACS Market (2026-2031)
The US Vendor Neutral Archive (VNA) & PACS Market was valued at $1315.6 Million in 2026 and projected to reach to $2154.8 Million by 2031, representing a compound annual growth rate of 10.4%. The US VNA and PACS market is positioned for sustained expansion through 2031, driven by healthcare providers' need for interoperable, cost-effective imaging solutions.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
US Vendor Neutral Archive (VNA) & PACS Market Trends and Insights
- The US market is driven by increasing adoption of interoperable imaging solutions across healthcare systems, regulatory mandates for data portability, and the shift toward value-based care models.
- In the US, healthcare providers are prioritizing VNA and PACS investments to streamline diagnostic workflows, reduce storage costs, and enhance patient data accessibility across multiple facilities. The US market's 10.4% compound annual growth rate significantly outpaces the global average, reflecting strong demand from integrated delivery networks, independent imaging centers, and hospital systems modernizing legacy infrastructure.
- US healthcare organizations are leveraging VNA and PACS solutions to comply with interoperability standards, improve clinical collaboration, and support teleradiology expansion.
- By 2031, the US market is expected to capture substantial value as digital transformation initiatives accelerate and cloud-based deployment models gain traction among US healthcare providers..
Key Market Statistics
- CAGR (2026-2031) 10.4% CAGR
- Market Size, 2026 ~USD 1315.6 Million
- Forecast, 2031 ~USD 2154.8 Million
- Country US
US Vendor Neutral Archive (VNA) & PACS Market Overview
Market Valuation Growth :
The US VNA and PACS market is valued at $1,315.6 million in 2026 and is projected to reach $2,154.8 million by 2031, representing a robust 10.4% CAGR, outpacing the global growth rate of 8.9%.
Interoperability Adoption :
US healthcare providers are increasingly adopting vendor-neutral archive solutions to enable seamless imaging data exchange across disparate healthcare systems, reducing vendor lock-in and improving clinical workflows.
Regulatory & Compliance Drivers :
Federal mandates for data portability, including 21st Century Cures Act requirements, are compelling US healthcare organizations to implement VNA solutions that ensure patient data accessibility and compliance.
Value-Based Care Transition :
The shift toward value-based care models in the US is accelerating VNA and PACS adoption, as providers leverage interoperable imaging platforms to improve patient outcomes and reduce operational costs.
US Vendor Neutral Archive (VNA) & PACS Market Dynamics
- Regulatory pressures, particularly around data portability and patient access rights, continue to fuel adoption across hospital systems and outpatient imaging centers.
- The transition to value-based care models further incentivizes investment in integrated imaging platforms that enhance clinical efficiency and reduce redundant imaging procedures. Looking ahead, the US market will benefit from increasing cloud-based VNA deployments, AI-enabled diagnostic tools, and enhanced cybersecurity measures.
- Healthcare organizations are prioritizing solutions that support multi-vendor environments while maintaining data integrity and compliance.
- As interoperability becomes a competitive differentiator, market growth will accelerate among integrated delivery networks and independent imaging providers seeking to modernize their infrastructure..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- The US VNA & PACS market will grow from $1,315.6M (2026) to $2,154.8M (2031) at a 10.4% CAGR, outpacing global growth rates.
- US healthcare providers are prioritizing interoperable imaging solutions to meet regulatory mandates and enhance clinical data accessibility.
- Cloud-based deployment models and teleradiology expansion are accelerating VNA and PACS adoption across US healthcare systems.
- The US market is driven by integrated delivery networks and hospital systems modernizing legacy infrastructure to support value-based care.
Vendor Neutral Archive (VNA) & PACS Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | INDIA (Modality) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 8.9% from 2026 to 2031 |
| Largest Segment | VNA (Product Type) |
| Market Size Base Year (Billions) | ~USD 5.6 (2026) |
| Revenue Forecast (Billions) | ~USD 8.57 (2031) |
| Segments Covered | Product Type, Modality, Deployment Model, Type, Vendor Type, Application, End User, Type 2023–2030 |
US Vendor Neutral Archive (VNA) & PACS Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product Type
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
- Pacs
- Vna
By Modality
- Ct
- Mammography
- Mri
- Pet
- Ultrasound
- X-Ray
By Deployment Model
- Cloud-Based Deployment Model
- Cloud-Based Deployment Models
- Hybrid Deployment Models
- On-Premises Deployment Models
By Type
- Department Pacs
- Department Vna
- Multi-Department Pacs
- Multi-Department Vna
- Multi-Site Pacs
- Multi-Site Vna
By Vendor Type
- Independent Vendors
- Third-Party Vendors
By Application
- Cardiology
- Neurology
- Obstetrics & Gynecology
- Oncology
- Orthopedic
- Other Applications
By End User
- Ambulatory Surgery Centers
- Diagnostic Centers
- Hospitals & Clinics
- Other End Users
By Type 2023–2030
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
Target Audience
- Healthcare IT Vendors : VNA and PACS solution providers need US market intelligence to develop competitive products, identify customer pain points, and capitalize on regulatory-driven adoption trends in the American healthcare market.
- Hospital Systems & Health Networks : US hospital administrators and IT directors require market insights to evaluate VNA and PACS investments, benchmark against peers, and align imaging infrastructure with interoperability mandates and value-based care goals.
- Private Equity & Investment Firms : Investors evaluating healthcare IT acquisition targets need US-specific market data to assess growth potential, competitive dynamics, and exit opportunities within the expanding VNA and PACS sector.
- Healthcare Consultants & Integrators : System integrators and healthcare consultants require detailed US market analysis to advise clients on VNA and PACS selection, implementation strategies, and ROI projections aligned with regulatory requirements.
- Medical Imaging Equipment Manufacturers : Imaging device manufacturers need US market insights to understand VNA and PACS integration requirements, identify partnership opportunities, and develop interoperable solutions that meet provider demands.
Key Companies in the US Vendor Neutral Archive (VNA) & PACS Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AGFA-GEVAERT GROUP | Belgium | Public Company | Healthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray and hardcopy film, and DR equipment,Sign & display and packaging printers, inks, and software, |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications), |
| SECTRA AB | Sweden | Public Company | Imaging IT Solutions (enterprise imaging, PACS/VNA, services),Secure Communications,Business Innovation (orthopedics, medical education, precision diagnostics IT), |
| GE HEALTHCARE | United States | Public Company | Imaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Maternal Infant, Anesthesia, Digital), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health, |
| HYLAND SOFTWARE, INC. | United States | Private Company | OnBase platform (ECM, workflow, case management),Healthcare imaging and interoperability (Hyland Healthcare, Acuo, NilRead, PACSgear, Mackinac),Legacy ECM/BPM suites (Perceptive Content, Perceptive Process, Saperion, NolijWeb), |
| ASPYRA, LLC | United States | Public Company | Laboratory information and workflow solutions,Imaging and orthopedic workflow solutions,Hardware, integration, and professional services, |
AGFA-GEVAERT GROUP
Agfa-Gevaert Group is a Belgian public company established in 1867 with 4,211 employees, operating across imaging and healthcare technology sectors.
FUJIFILM HOLDINGS CORPORATION
Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, engaged in imaging, healthcare, and materials technology.
SECTRA AB
Sectra AB is a Swedish public company established in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.
GE HEALTHCARE
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees, providing medical imaging and healthcare technology solutions.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company established in 1891 with 64,317 employees, operating in healthcare, lighting, and consumer electronics.
HYLAND SOFTWARE, INC.
Hyland Software, Inc. is a United States private company established in 1991 with 336 employees, developing content management and workflow automation solutions.
ASPYRA, LLC
Aspyra, LLC is a United States public company founded in 1978 with 70 employees, specializing in healthcare imaging and information management systems.
Reasons to Buy this Report
- Market Size & Growth Validation : Quantified US market data with precise valuations ($1,315.6M in 2026 to $2,154.8M in 2031) and a 10.4% CAGR enables accurate financial forecasting and investment decision-making for stakeholders.
- Regulatory Landscape Intelligence : Understand how US-specific compliance mandates (21st Century Cures Act, data portability rules) are reshaping VNA and PACS adoption, helping vendors and providers align product strategies with regulatory requirements.
- Competitive Positioning Insights : Identify market dynamics specific to the US healthcare ecosystem, including interoperability trends and value-based care adoption, to benchmark competitive positioning and identify growth opportunities.
- Strategic Investment Planning : Leverage US-focused market analysis to prioritize geographic expansion, product development, and partnership strategies within the fastest-growing healthcare IT segment in North America.
- Customer Segmentation Data : Access detailed insights into US healthcare provider segments (hospital systems, outpatient centers, independent imaging facilities) to tailor sales strategies and marketing messaging effectively.
Frequently asked questions
What is the current size of the US VNA & PACS market in 2026?
The US VNA & PACS market is valued at $1,315.6 million in 2026, with strong growth momentum driven by healthcare digitalization and interoperability requirements.
What is the projected market size for the US VNA & PACS market by 2031?
The US VNA & PACS market is projected to reach $2,154.8 million by 2031, representing a 10.4% compound annual growth rate over the forecast period.
Why is the US VNA & PACS market growing faster than the global average?
The US market benefits from advanced healthcare infrastructure, strong regulatory focus on interoperability, widespread adoption of cloud technologies, and significant investment in digital health transformation initiatives.
What are the primary drivers of VNA & PACS adoption in the US?
Key drivers include regulatory mandates for data portability, the shift to value-based care models, teleradiology expansion, cost reduction pressures, and the need for seamless clinical collaboration across healthcare systems.
Which US healthcare organizations are leading VNA & PACS adoption?
Integrated delivery networks, large hospital systems, independent imaging centers, and specialty imaging providers are leading adoption to modernize legacy infrastructure and improve operational efficiency.
RESEARCH METHODOLOGY
The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARIES
Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.
Market Definition
VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.
Key Stakeholders
- VNA & PACS vendors
- Government bodies
- Healthcare service providers
- Clinical/Physician centers
- Healthcare professionals
- Health IT service providers
- Healthcare associations/institutes
- Ambulatory care centers
- Venture capitalists
- Distributors and resellers
- Maintenance and support service providers
- Integration service providers
- Healthcare players
Report Objectives
- To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
- To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries
Get the Full Vendor Neutral Archive (VNA) & PACS Market Report
Full forecast, segment splits, and company analysis for all Vendor Neutral Archive (VNA) & PACS Market.
- Canada Vendor Neutral Archive (VNA) & PACS Market
- UK Vendor Neutral Archive (VNA) & PACS Market
- Germany Vendor Neutral Archive (VNA) & PACS Market
- France Vendor Neutral Archive (VNA) & PACS Market
- Italy Vendor Neutral Archive (VNA) & PACS Market
- Spain Vendor Neutral Archive (VNA) & PACS Market
- China Vendor Neutral Archive (VNA) & PACS Market
- Japan Vendor Neutral Archive (VNA) & PACS Market
- India Vendor Neutral Archive (VNA) & PACS Market
- Brazil Vendor Neutral Archive (VNA) & PACS Market
- Mexico Vendor Neutral Archive (VNA) & PACS Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report